The global biobanks market was valued at USD 200.65 million in 2016 and is projected to reach USD 270.54 million by 2018, at a CAGR of 6.16% during the forecast period from 2014 to 2021.
Global Biobanks Market- Market Dynamics
The report details several driving and restraining factors for the global biobanks market. Some of them are listed below.
The vision of personalized medicine
Poor productivity rate of the pharmaceutical industry with respect to the new drug approvals
Need to contain the ever-increasing healthcare costs
Research and development processes from early discovery through clinical trials
Advances in regenerative medicine, drug discovery and biobanking techniques
Privacy, confidentiality and surveillance issues
Access policies and procedures
Regulation-based issues with biobanking procedures
Fear of privatization
Lack of proper governance
Cost competitive procedures
The report segments the market on the basis of type, equipment, application and geography.
On the basis of type, the market has been segmented into optimized pre-formulated media and non-optimized isotonic formulated media
On the basis of equipment, the market is segmented into refrigerators, ice machines, freezers, cryogenic storage systems, alarm monitoring systems, and LN2 supply tanks
On the basis of application, the market is segmented into drug discovery, biobanking procedures, and regenerative medicine
On the basis of geography, the market is segmented into North America (U.S.A., Canada, and Mexico), Europe (U.K., Germany, France, and Spain), Asia-Pacific (India, China, Japan, and South Korea), and the Rest of the World.
From the geographical point of view, the US has the largest market share, followed by the European market. Recent developments in this market have also contributed to the growth of the emerging markets. They are expected to show stiff competition to the developed economies.
However, the rapid growth in the population of the Asia-Pacific countries is expected to affect the market of the developed countries. Europe is the largest biorepositories market due to the huge demand from the Netherlands, Italy, Germany, the U.K., and among other countries.
Some of the key players in the market are:
Core Dynamics Ltd.
Bioniche Pharma USA LLC
Cell & Tissue Systems LLC
Key Deliverables in the Study
Market analysis for the biobanks market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the biobanks market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
1.1 Report Description
1.2 Study Assumptions
1.3 Market Definition
2. Research Methodology
2.2 Analysis Methodology
2.3 Study Phases
2.3.1 Secondary Research
2.3.2 Discussion Guide
2.3.3 Market Engineering & Econometric Model
2.3.4 Expert Validation
2.4 Study timeline
3. Executive Summary
4. Market Overview
4.2 Market Dynamics
4.2.1 Market Drivers
184.108.40.206 Investment by government & non- government organizations
Thanks for purchasing our study on . The report will be delivered to your email in PDF format with in 24-48 hrs after ensuring the latest developments in the market are included. For any queries you can reach us at email@example.com..
Sorry!! your transcation has failed because your card is declined.